Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Carol T, Bussey"'
Autor:
Lorna J. Daniels, Marco Annandale, Parisa Koutsifeli, Xun Li, Carol T. Bussey, Isabelle van Hout, Richard W. Bunton, Philip J. Davis, Sean Coffey, Rajesh Katare, Regis R. Lamberts, Lea M. D. Delbridge, Kimberley M. Mellor
Publikováno v:
Nutrition & Diabetes, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Diabetes is associated with cardiac metabolic disturbances and increased heart failure risk. Plasma fructose levels are elevated in diabetic patients. A direct role for fructose involvement in diabetic heart pathology has not been investigat
Externí odkaz:
https://doaj.org/article/71cc5f2d30f7420783f9df21ea649854
Autor:
Carol T. Bussey, Aram A. Babakr, Rachael R. Iremonger, Isabelle vanHout, Gerard T. Wilkins, Regis R. Lamberts, Jeffrey R. Erickson
Publikováno v:
Physiological Reports, Vol 8, Iss 5, Pp n/a-n/a (2020)
Abstract Purpose Increasing cohorts of patients present with diabetic cardiomyopathy, and with no targeted options, treatment often rely on generic pharmaceuticals such as β‐blockers. β‐blocker efficacy is heterogenous, with second generation
Externí odkaz:
https://doaj.org/article/41b9ebdf408e49ab996df8c593222994
Autor:
Sunil Jit R.J. Logantha, James O. Tellez, Mark R. Boyett, Eman S.H. Abd Allah, Cali Anderson, P. Mesirca, Natalie Chandler, Matthew K. Lancaster, Matteo E. Mangoni, Joseph Yanni, George Hart, Jonathan P. Ariyaratnam, Matthew Smith, Henggui Zhang, Robert S. Stephenson, Luke Stuart, Gwilym M. Morris, Claire Wilson, Xue Cai, Rudi Billeter, Alicia D'Souza, Annalisa Bucchi, Sandra C. Jones, Oliver J. Monfredi, Carol T. Bussey, Shu Nakao
Publikováno v:
Progress in Biophysics and Molecular Biology
Progress in Biophysics and Molecular Biology, Elsevier, 2021, 166, pp.61-85. ⟨10.1016/j.pbiomolbio.2021.06.008⟩
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
Boyett, M, Yanni Gerges, J, Tellez, J O, Bucchi, A, Mesirca, P, Cai, X, Logantha, S J R J, Wilson, C, Anderson, C, Ariyaratnam, J, Stuart, L, Nakao, S, Allah, E A, Jones, S A, Lancaster, M, Stephenson, R S, Chandler, N, Smith, M, Bussey, C, Monfredi, O, Morris, G, Billeter, R, Mangoni, M E, Zhang, H, Hart, G & D'Souza, A 2021, ' Regulation of sinus node pacemaking and atrioventricular node conduction by HCN channels in health and disease ', Progress in biophysics and molecular biology, vol. 166, pp. 61-85 . https://doi.org/10.1016/j.pbiomolbio.2021.06.008
Progress in Biophysics and Molecular Biology, Elsevier, 2021, 166, pp.61-85. ⟨10.1016/j.pbiomolbio.2021.06.008⟩
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
Boyett, M, Yanni Gerges, J, Tellez, J O, Bucchi, A, Mesirca, P, Cai, X, Logantha, S J R J, Wilson, C, Anderson, C, Ariyaratnam, J, Stuart, L, Nakao, S, Allah, E A, Jones, S A, Lancaster, M, Stephenson, R S, Chandler, N, Smith, M, Bussey, C, Monfredi, O, Morris, G, Billeter, R, Mangoni, M E, Zhang, H, Hart, G & D'Souza, A 2021, ' Regulation of sinus node pacemaking and atrioventricular node conduction by HCN channels in health and disease ', Progress in biophysics and molecular biology, vol. 166, pp. 61-85 . https://doi.org/10.1016/j.pbiomolbio.2021.06.008
The funny current, I f, was first recorded in the heart 40 or more years ago by Dario DiFrancesco and others. Since then, we have learnt that I f plays an important role in pacemaking in the sinus node, the innate pacemaker of the heart, and more rec
Autor:
Sajida Parveen, Paddy H. S. Cheah, Luke P. I. Worthington, Roseanna A. Smither, Michelle L. Munro, Carol T. Bussey, Regis R. Lamberts, Peter P. Jones
Publikováno v:
Molecular and Cellular Biochemistry.
Publikováno v:
Nitric oxide : biology and chemistry. 129
Nitric oxide (NO) is a key vasodilatory signalling molecule and NO releasing molecules (NO donors) are being examined as potential treatments for many pathologies. The photoresponsive NO donor tert-dodecane S-nitrosothiol (tDodSNO) has been designed
Autor:
Shivani Sethi, Regis R. Lamberts, Gregory T. Bouwer, Colin H. Brown, Rachael A. Augustine, Carol T. Bussey, Daryl O. Schwenke, Michael R. Perkinson, Isaiah Cheong
Publikováno v:
Journal of Neuroendocrinology. 33
Increased cardiac sympathetic nerve activity in type 2 diabetes mellitus (DM) suggests impaired autonomic control of the heart. However, the central regions that contribute to the autonomic cardiac pathologies in type 2 DM are unknown. Therefore, we
Autor:
Carol T. Bussey, Gillian Hughes, Andrew Bahn, Patricia A. Cragg, Regis R. Lamberts, Ingrid C. Fomison-Nurse, Rosalind F. Cook
Publikováno v:
Experimental Physiology. 104:808-818
NEW FINDINGS What is the central question of this study? Are there specific contributions of β1 - and β2 -adrenoceptor subtypes to the impaired β-adrenoceptor responsiveness of the type 2 diabetic heart? What is the main finding and its importance
Autor:
Michael R. Perkinson, Isaiah Cheong, Regis R. Lamberts, Daryl O. Schwenke, Colin H. Brown, Rachael A. Augustine, Shivani Sethi, Gregory T. Bouwer, Carol T. Bussey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c3a8597cb3ff008195aaf6c6ed5da1c
https://doi.org/10.1111/jne.13016/v2/response1
https://doi.org/10.1111/jne.13016/v2/response1
Autor:
Rajesh Katare, L. Daniels, Parisa Koutsifeli, Carol T. Bussey, Isabelle van Hout, Sean Coffey, Kimberley M. Mellor, Lea M.D. Delbridge, Philip Davis, Richard W. Bunton, Regis R. Lamberts, Marco Annandale, X. Li
Publikováno v:
Nutrition & Diabetes
Nutrition & Diabetes, Vol 11, Iss 1, Pp 1-7 (2021)
Nutrition & Diabetes, Vol 11, Iss 1, Pp 1-7 (2021)
Diabetes is associated with cardiac metabolic disturbances and increased heart failure risk. Plasma fructose levels are elevated in diabetic patients. A direct role for fructose involvement in diabetic heart pathology has not been investigated. The g
Autor:
Jeffrey R. Erickson, Carol T. Bussey, Isabelle van Hout, Rachael R Iremonger, Gerard T. Wilkins, Regis R. Lamberts, Aram A. Babakr
Publikováno v:
Physiological Reports
Physiological Reports, Vol 8, Iss 5, Pp n/a-n/a (2020)
Physiological Reports, Vol 8, Iss 5, Pp n/a-n/a (2020)
Purpose Increasing cohorts of patients present with diabetic cardiomyopathy, and with no targeted options, treatment often rely on generic pharmaceuticals such as β‐blockers. β‐blocker efficacy is heterogenous, with second generation β‐block